Meyka Pro banner
Becton, Dickinson and Company

Becton, Dickinson and Company (BDX) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

BDXNYSE
HealthcareMedical - Instruments & Supplies
$192.00
$4.38(2.33%)
U.S. Market opens in 62h 32m

Becton, Dickinson and Company (BDX)

Meyka AI Score

Z

Key Financials

Market Cap52.9B
P/E Ratio57.61
EPS (TTM)$13.00
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$171.16
3 Months$166.39
1 Year Target$147.28

BDX Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Becton, Dickinson and Company (NYSE: BDX) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Becton, Dickinson and Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BDX on the NYSE shows an RSI of 78.78, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $147.28 for the NYSE listing.

Key metrics behind Becton, Dickinson and Company's NYSE-traded stock include a P/E ratio of 57.61 and a market capitalization of 52.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BDX on the NYSE.

Price Performance (NYSE: BDX)

1-Day Change
2.32%
5-Day Change
5.41%
1-Month Change
24.79%
3-Month Change
31.26%
6-Month Change
3.55%
Year-to-Date (YTD) Change
25.82%
1-Year Change
24.19%
3-Year Change
-11.40%
5-Year Change
0.18%
All-Time (Max) Change
730.32%

Contact Information

201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

720,000 Employees
IPO DateFeb 21, 1973
CountryUS
Actively Trading

Frequently Asked Questions